Skip to main content
Clinical Trials/NCT06454058
NCT06454058
Terminated
Not Applicable

Association Between Euploid Embryo Grade and Maternal Age, a Retrospective Cross-sectional Study

Inception Fertility Research Institute, LLC1 site in 1 country502 target enrollmentJune 7, 2024
ConditionsFertility

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fertility
Sponsor
Inception Fertility Research Institute, LLC
Enrollment
502
Locations
1
Primary Endpoint
Embryo Grade
Status
Terminated
Last Updated
9 months ago

Overview

Brief Summary

Background: Advanced maternal age (AMA) is associated with a reduction in live birth rate (LBR) after ART cycles. The main reason for this reduction is the lower number of oocytes aspirated, the number of developing embryos and the low number of euploid embryos available for transfer. The impact of age on success rates after the transfer of an euploid embryo has been a matter of discussion, with a recent meta-analysis showing a reduction in LBR after the transfer of an euploid blastocyst to women of AMA (1). There could be many reasons for this reduced LBR but they can be categorized into two broad categories - the uterus (including the mother's health) and the embryo (including the oocyte and the sperm).

It is possible that factors associated with reduced embryo quality would manifest in a lower embryo grade.

Detailed Description

Objective: To study if there is an association between advanced maternal age and lower embryo grading of euploid embryos. Hypothesis: Advanced maternal age is associated with a lower embryonic grade in euploid embryos. Study Design: This is a retrospective cross-sectional study of euploid embryos from patients who have completed IVF with PGT-A testing at a fertility clinic in The Prelude Network (US sites only). A comparison of embryo grade between different age groups (\<35, 40+) will be done after controlling for baseline demographic characteristics.

Registry
clinicaltrials.gov
Start Date
June 7, 2024
End Date
March 26, 2025
Last Updated
9 months ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Inception Fertility Research Institute, LLC
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who have completed IVF egg retrieval with PGT-A testing at a fertility clinic in The Prelude Network (US clinics, excluding NYU)
  • PGT biopsy was conducted in 2023,
  • PGT biopsy was performed on blastocyst stage embryo,
  • PGT-A result is euploid.

Exclusion Criteria

  • PGT-A result is mosaic,
  • Embryos in which PGT-M was done and were found to be carriers of the mutation,
  • Embryos in which PGT-SR was done and were found to be carriers of the structural rearrangement.

Outcomes

Primary Outcomes

Embryo Grade

Time Frame: 6 months

Embryo grade for PGT-A confirmed euploid embryos

Study Sites (1)

Loading locations...

Similar Trials